Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Pericoronary fat attenuation index in computed tomography angiography is associated with mortality in end-stage renal
Nam-Jun Cho1, Bo Da Nam2, Samel Park1
1Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
Insights
Pericoronary fat attenuation index (FAI) measured at the left anterior descending artery predicts long-term mortality in end-stage renal disease (ESRD) patients. This finding may enable early intervention strategies for ESRD patients.
Area of Science:
- Cardiology
- Nephrology
- Radiology
Background:
- Increased pericoronary fat attenuation index (FAI) on computed tomography angiography (CTA) correlates with higher mortality in the general population.
- The predictive value of pericoronary FAI for long-term outcomes in chronic kidney disease (CKD) patients remains unestablished.
Purpose of the Study:
- To evaluate the utility of CTA-derived pericoronary FAI in predicting mortality among CKD patients, including those with end-stage renal disease (ESRD).
Main Methods:
- A retrospective longitudinal cohort study involving 268 CKD patients who underwent coronary CTA.
- Pericoronary FAI was mapped and analyzed in three major proximal coronary arteries, with a focus on the left anterior descending (LAD) artery.
- Multivariable Cox regression models were employed to assess the prognostic value of pericoronary FAI for long-term mortality.
Main Results:
- Among 209 participants with LAD FAI measurements, pericoronary FAI at the LAD was not significantly associated with all-cause mortality risk across all CKD groups.
- However, ESRD patients with elevated pericoronary FAI demonstrated a significantly higher adjusted risk of all-cause mortality compared to those with low FAI (HR, 2.26; 95% CI, 1.11-4.61).
Conclusions:
- Pericoronary FAI measured at the LAD artery is a significant predictor of long-term mortality in ESRD patients.
- This finding suggests pericoronary FAI could facilitate early primary interventions in ESRD patients.
Background:
An increased pericoronary fat attenuation index (FAI) on computed tomography angiography (CTA) is associated with increased all-cause and cardiac mortality in the general population. However, the ability of pericoronary FAI to predict long-term outcomes in chronic kidney disease (CKD) patients is unknown.
Methods:
In this single-center retrospective longitudinal cohort study, we assessed the utility of CTA-based pericoronary FAI measurement to predict mortality of CKD patients, including those with end-stage renal disease (ESRD). Mapping and analysis of pericoronary FAI involved three major proximal coronary arteries. The prognostic value of pericoronary FAI for long-term mortality was assessed with multivariable Cox regression models.
Results:
Among 268 CKD participants who underwent coronary CTA, 209 participants with left anterior descending artery (LAD) FAI measurements were included. The pericoronary FAI measured at the LAD was not significantly associated with adjusted risk of allcause mortality (hazard ratio [HR], 2.08; 95% confidence interval [CI], 0.94-3.51) in any CKD group. However, ESRD patients with elevated pericoronary FAI values had a greater adjusted risk of all-cause mortality compared with the low-FAI group (HR, 2.26; 95% CI, 1.11-4.61).
Conclusion:
The pericoronary FAI measured at the LAD predicted long-term mortality in patients with ESRD, which could provide an opportunity for early primary intervention in ESRD patients.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Acute Coronary Syndrome III: Diagnostic Studies
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

